aminooxyacetic acid has been researched along with Adverse Drug Event in 1 studies
Aminooxyacetic Acid: A compound that inhibits aminobutyrate aminotransferase activity in vivo, thereby raising the level of gamma-aminobutyric acid in tissues.
(aminooxy)acetic acid : A member of the class of hydroxylamines that is acetic acid substituted at postion 2 by an aminooxy group. It is a compound which inhibits aminobutyrate aminotransferase activity in vivo, resulting in increased levels of gamma-aminobutyric acid in tissues.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aleo, MD | 1 |
| Avery, MJ | 1 |
| Beierschmitt, WP | 1 |
| Drupa, CA | 1 |
| Fortner, JH | 1 |
| Kaplan, AH | 1 |
| Navetta, KA | 1 |
| Shepard, RM | 1 |
| Walsh, CM | 1 |
1 other study available for aminooxyacetic acid and Adverse Drug Event
| Article | Year |
|---|---|
The use of explant lens culture to assess cataractogenic potential.
Topics: Adenosine Triphosphate; Aminooxyacetic Acid; Animals; Benzopyrans; Biotransformation; Cataract; Drug | 2000 |